Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Income Statement [Abstract]    
Revenue
Expenses:    
Research and development 4,768,372 6,645,771
General and administrative 2,538,497 3,269,723
Loss from operations (7,306,869) (9,915,494)
Other income (expense), net 38,098 (2,010)
Interest expense (11,081) (8,045)
Foreign currency exchange gain (loss), net (781,546) 116,924
Loss before income taxes (8,061,398) (9,808,625)
Income tax (benefit) expense
Net loss $ (8,061,398) $ (9,808,625)
Basic and diluted net loss per common share $ (4.50) $ (5.51)
Weighted average shares used in computing basic and diluted net loss per common share 1,790,301 1,780,788